B. Mirtsching

2.3k citations
27 papers · 1.3k · 1 hit paper · h-index 12

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Cancer Genomics and Diagnostics

Papers in

B. Mirtsching

26 papers receiving 1.3k citations

B. Mirtsching's Hit Papers

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 2010 · 500 citations
5000+5+10Years since publication100200300400500

Peers

B. Mirtsching
Comparison fields: 5 of 63
  • Oncology 1.1k
  • Cancer Research 288
  • Hepatology 131
  • Pulmonary and Respiratory Medicine 459
  • Hematology 104
Replace B. Schüll with:
B. Schüll Austria
Rodolfo Mattioli Italy
Glenwood D. Goss Canada
Anna Maria Frezza Italy
Ralph Wong Canada
Claudio Dazzi Italy
Roland Sonntag Switzerland
Roopinder Gillmore United Kingdom
H. Ulrich-Pur Austria
Andrew Dean Australia
B. Mirtsching relative to B. Schüll Austria B. Schüll's profile →
Citations per field
00.5×5.5×
B. Schüll · 1×
Citations per year

Countries citing papers authored by B. Mirtsching

Since Specialization
Citations

This map shows the geographic impact of B. Mirtsching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mirtsching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mirtsching more than expected).

Fields of papers citing papers by B. Mirtsching

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Mirtsching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mirtsching. The network helps show where B. Mirtsching may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Mirtsching, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Mirtsching Line = papers co-authored together B. Mirtsching links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
Hit paper breakdown →
2010500
2 2006420
3 200480
4 201158
5
Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
200656
6 200741
7 200435
8 200527
9 200520
10 200417
11 201116
12
Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
200216
13
Every-2-Week Darbepoetin Alfa Is Comparable to rHuEPO in Treating Chemotherapy-Induced Anemia
200210
14 20107
15 20047
16 20077
17 20056
18 20045
19 20084
20 19923

About B. Mirtsching

B. Mirtsching is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Genetics and Genetics, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Erythropoietin and Anemia Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers), Statistical Methods in Clinical Trials (4 papers), Blood disorders and treatments (4 papers), Neutropenia and Cancer Infections (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (288 citations), Hepatology (131 citations), Pulmonary and Respiratory Medicine (459 citations) and Hematology (104 citations). B. Mirtsching has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Allen Lee Cohn, Heinz‐Josef Lenz, Eric Van Cutsem, Andrew W. Pippas, Robert J. Mayer, N. Azarnia, Philip J. Gold, Alok A. Khorana, Eileen M. O’Reilly and Philip A. Philip. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Survey of Ophthalmology, BMC Cancer and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact